Thrive Earlier Detection
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $367M
Investors
- 21
About Thrive Earlier Detection
Established in 2019 and based in Massachusetts, US, Thrive Earlier Detection Corp. is a healthcare company that develops CancerSEEK, a blood-based test that combines liquid biopsy technology and machine learning engine to detect multiple types of cancer at an earlier stage.
Who invested in Thrive Earlier Detection
21 investors across 2 rounds
See all investors in Thrive Earlier Detection
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Thrive Earlier Detection
Who invested in Thrive Earlier Detection?
Thrive Earlier Detection has 21 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thrive Earlier Detection raised?
Thrive Earlier Detection has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Thrive Earlier Detection last raise money?
Thrive Earlier Detection's most recent round on record is a Series B, in Jul 2020.
What does Thrive Earlier Detection do?
Established in 2019 and based in Massachusetts, US, Thrive Earlier Detection Corp.
Where is Thrive Earlier Detection headquartered?
Thrive Earlier Detection is headquartered in Cambridge, US.
Which VCs invest in companies like Thrive Earlier Detection?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Thrive Earlier Detection's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Thrive Earlier Detection? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.